Premenstrual Dysphoric Disorder and the Controversy Over Diagnosis and Treatment

Thesis (M.Nurs.), College of Nursing, Washington State UniversityPremenstrual dysphoric. disorder has received great attention and controversy since it was first adapted into the DSM IV in 1994. Since that time, treatment options have stolen the spotlight, and limited focus has occurred on the actual disorder. The diagnosis of premenstrual dysphoric disorder (PMDD), risks and benefits ofthe diagnosis, and alternative treatment modalities used in a clinical setting will be reviewed in this manuscript. The most alarming risk of the diagnosis includes a misdiagnosis and the possibility of covering up an underlying condition. The major benefit of correct diagnosis is likely improvement of health related quality of life through symptom control and management. A major problem is that accurate diagnostic screening tools are not being utilized properly and effectively in the clinical setting. The treatment ofPMDD is diverse and complicated. If the appropriate diagnostic measures are not taken an underlying medical condition, including a psychiatric diagnosis may be missed. In the clinical setting this is important, because approximately 5-8% of the female population is affected by premenstrual dysphoric disorder, which is proven to have a significant effect on lifestyle, work function, relationships, and social interaction. By appropriately diagnosing this disorder, and using evidence based practice to treat, the symptoms can be controlled and burdens on activities of daily living can be lifted